• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.43% Nasdaq Up 0.03%

    Geron Corporation (GERN)

    -NasdaqGS
    4.20 Down 0.12(2.78%) 3:04PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.32
    Open:4.32
    Bid:4.18 x 3400
    Ask:4.19 x 2900
    1y Target Est:5.50
    Beta:1.92
    Next Earnings Date:N/A
    Day's Range:4.13 - 4.32
    52wk Range:1.76 - 4.67
    Volume:1,880,329
    Avg Vol (3m):2,474,940
    Market Cap:663.97M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 2.78%663.97M
    BMYUp 1.23%113.90B
    GSKDown 0.49%100.81B
    NVSUp 0.30%239.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):561.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.07
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-11.60

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback